2028 Revenue (run-rate)
€2,956,000
incl. take-rate + subs
B2B logos by 2028
50
employers under contract
Active therapists 2028
120
verified supply
EBITDA 2028
€2,316,000
78% margin
Go-to-market & expansion
- Beachhead: Estonia with dense verified supply and B2B pilots.
- Baltics scale: Latvia/Lithuania leveraging cross-border therapist network.
- Nearby growth: Poland and Nordics via employer channels and partnerships.
Business model
- Marketplace take-rate on sessions (24% blended).
- B2B subscriptions (access, analytics, rollout support).
- Therapist Pro subscriptions (tools, priority, data insights).
GMV
Therapy spend flowing through the platform.
EBITDA
Break-even in 2027; strong operating leverage by 2028.
Revenue (annual)
+ profitability from 2027; capital efficient growth.
Financial plan (2026–2028)
All numbers in euros (€); sessions include both online and in-person.
Why now
- Employer budgets shifting to measurable wellbeing impact.
- Hybrid care preferred: online convenience + in-person depth.
- Regulatory and cultural tailwinds in EU markets.
Moat
- Verified supply + outcomes & retention data.
- Matching that optimizes for fit and recurrence.
- Employer integrations & procurement readiness.
Key risks
- Therapist liquidity when entering new regions.
- Price sensitivity vs. quality and verification costs.
- Enterprise sales cycles and localization.
Interested in partnering or investing?
Request our deck and data room. We’ll follow up quickly.